Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

3D Drug Eluting Balloons Applications in Healthcare Market by Component (Devices, Materials, Services), by Technology (Droplet Deposition, Photo polymerization, Laser Beam Melting, Electronic Beam Melting, Laminated Object Manufacturing), by Application (External Wearable Devices, Clinical Study Devices, Implants, Tissue Engineering) and by End User (Medical and Surgical Centers, Pharmaceutical and Biotechnology Companies, Academic Institutions): Global Opportunity Analysis and Industry Forecast, 2023-2032

A12571

Pages: NA

Charts: NA

Tables: NA

3D technology has made enormous encroachments in various application areas in the diverse industry globally. The great potential of additive printing technology in presenting new paradigms in the healthcare sector. 3D technology is being rapidly adopted in advanced radiology. The technology has made exceptional advances in medical imaging that are considered the essence of the healthcare industry. An aim of using medical imaging modalities allowed by 3D technology is to dramatically improve the efficiency of diagnosis of various diseases like cancer, mainly by allowing clinicians to improve the visualization of the anatomy.

COVID-19 Impact analysis

COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

There has been an increase in the demand for medical supplies to take care of infected population. Respiratory support devices such as atomizers, life-support machines, oxygen generators, and monitors are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. There is an increase in the need for medical supplies, both from healthcare professionals and civil population for precautionary measures, owing to the rise in number of COVID-19 cases worldwide. Manufacturers of these products have a chance to capitalize this increased demand for medical supplies to ensure adequate and continuous supply of personal protective equipment in the market. Therefore, COVID 19 is expected to have a significant impact on the 3D applications in healthcare market.

Top Impacting Factors

  • Rise in demand for implant customizations during surgical procedures, metal 3D printing is a cost-effective and precise method for the manufacturing of template components, less post-operative strain, less treatment time, minimally invasive, increase in use of this technology in many applications like  3D printed organs, transplantation, and drug delivery, are the factors that drive the growth of the 3D applications in the healthcare market
  • In addition, increase in healthcare expenditure; collaborations & partnerships between key players to facilitate the launch of the novel developed technology in the market, and rise in R&D activities; are some factors, which boost the market growth for 3D applications in healthcare
  • However, high cost of 3D printers, lack of skilled professionals, and stringent government regulations hinder the market growth.

Market Trends

Collaboration is the key strategy adopted by players in 3D printing in Healthcare Market.

In February 2018, AMBER (Advanced Materials and Bioengineering Research) collaborated with Johnson & Johnson to launch 3D bio print center of excellence.

Key Benefits of the Report

  • This study presents the analytical depiction of the 3D applications in healthcare industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the 3D applications in healthcare market share.
  • The current market is quantitatively analyzed to highlight the 3D applications in healthcare market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed the 3D applications in healthcare market analysis based on competitive intensity and how the competition will take shape in coming years

Questions answered in the 3D applications in healthcare Report

  • Which are the leading players active in the 3D applications in healthcare market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What is "3D applications in healthcare"?
  • What is "3D applications in healthcare" Market prediction in the future?
  • Who are the leading global players in the "3D applications in healthcare" Market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the "3D applications in healthcare" Market report?

Key Market Segments

  • By Component
    • Devices
    • Materials
    • Services
  • By Technology
    • Droplet Deposition
      • Fused Deposition Modeling Technology
      • Low-temperature Deposition Manufacturing
      • Multiphase Jet Solidification
    • Photo polymerization
      • Stereo lithography
      • Continuous Liquid Interface Production
      • Two-photon Polymerization
    • Laser Beam Melting
      • Selective Laser Sintering
      • Selective Laser Melting
      • Direct Metal Laser Sintering
    • Electronic Beam Melting
    • Laminated Object Manufacturing
  • By Application
    • External Wearable Devices
    • Clinical Study Devices
    • Implants
    • Tissue Engineering
  • By End User
    • Medical and Surgical Centers
    • Pharmaceutical and Biotechnology Companies
    • Academic Institutions
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA


Key Market Players

  • Medtronic
  • MicroPort Scientific Corporation
  • TERUMO Corporation
  • Cook Medical
  • C.R.Bard Inc.
  • Cardionovum GmbH
  • Boston Scientific
  • Biotronik SE & Co. KG
  • Biosensors International
  • Abbot Vascular
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET, BY COMPONENT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Component

    • 4.2. Devices

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Materials

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Services

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET, BY TECHNOLOGY

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Technology

    • 5.2. Droplet Deposition

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

      • 5.2.4. Fused Deposition Modeling Technology

        • 5.2.4.1. Market Size and Forecast
      • 5.2.4. Low-temperature Deposition Manufacturing

        • 5.2.4.1. Market Size and Forecast
      • 5.2.4. Multiphase Jet Solidification

        • 5.2.4.1. Market Size and Forecast
    • 5.3. Photo Polymerization

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

      • 5.3.4. Stereo lithography

        • 5.3.4.1. Market Size and Forecast
      • 5.3.4. Continuous Liquid Interface Production

        • 5.3.4.1. Market Size and Forecast
      • 5.3.4. Two-photon Polymerization

        • 5.3.4.1. Market Size and Forecast
    • 5.4. Laser Beam Melting

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

      • 5.4.4. Selective Laser Sintering

        • 5.4.4.1. Market Size and Forecast
      • 5.4.4. Selective Laser Melting

        • 5.4.4.1. Market Size and Forecast
      • 5.4.4. Direct Metal Laser Sintering

        • 5.4.4.1. Market Size and Forecast
    • 5.5. Electronic Beam Melting

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Laminated Object Manufacturing

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

  • CHAPTER 6: 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET, BY APPLICATION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Application

    • 6.2. External Wearable Devices

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Clinical Study Devices

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Implants

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Tissue Engineering

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

  • CHAPTER 7: 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET, BY END USER

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By End User

    • 7.2. Medical And Surgical Centers

      • 7.2.1. Key Market Trends, Growth Factors and Opportunities

      • 7.2.2. Market Size and Forecast, By Region

      • 7.2.3. Market Share Analysis, By Country

    • 7.3. Pharmaceutical And Biotechnology Companies

      • 7.3.1. Key Market Trends, Growth Factors and Opportunities

      • 7.3.2. Market Size and Forecast, By Region

      • 7.3.3. Market Share Analysis, By Country

    • 7.4. Academic Institutions

      • 7.4.1. Key Market Trends, Growth Factors and Opportunities

      • 7.4.2. Market Size and Forecast, By Region

      • 7.4.3. Market Share Analysis, By Country

  • CHAPTER 8: 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET, BY REGION

    • 8.1. Market Overview

      • 8.1.1 Market Size and Forecast, By Region

    • 8.2. North America

      • 8.2.1. Key Market Trends and Opportunities

      • 8.2.2. Market Size and Forecast, By Component

      • 8.2.3. Market Size and Forecast, By Technology

      • 8.2.4. Market Size and Forecast, By Application

      • 8.2.5. Market Size and Forecast, By End User

      • 8.2.6. Market Size and Forecast, By Country

      • 8.2.7. U.S. 3d Drug Eluting Balloons Applications In Healthcare Market

        • 8.2.7.1. Market Size and Forecast, By Component
        • 8.2.7.2. Market Size and Forecast, By Technology
        • 8.2.7.3. Market Size and Forecast, By Application
        • 8.2.7.4. Market Size and Forecast, By End User
      • 8.2.8. Canada 3d Drug Eluting Balloons Applications In Healthcare Market

        • 8.2.8.1. Market Size and Forecast, By Component
        • 8.2.8.2. Market Size and Forecast, By Technology
        • 8.2.8.3. Market Size and Forecast, By Application
        • 8.2.8.4. Market Size and Forecast, By End User
      • 8.2.9. Mexico 3d Drug Eluting Balloons Applications In Healthcare Market

        • 8.2.9.1. Market Size and Forecast, By Component
        • 8.2.9.2. Market Size and Forecast, By Technology
        • 8.2.9.3. Market Size and Forecast, By Application
        • 8.2.9.4. Market Size and Forecast, By End User
    • 8.3. Europe

      • 8.3.1. Key Market Trends and Opportunities

      • 8.3.2. Market Size and Forecast, By Component

      • 8.3.3. Market Size and Forecast, By Technology

      • 8.3.4. Market Size and Forecast, By Application

      • 8.3.5. Market Size and Forecast, By End User

      • 8.3.6. Market Size and Forecast, By Country

      • 8.3.7. France 3d Drug Eluting Balloons Applications In Healthcare Market

        • 8.3.7.1. Market Size and Forecast, By Component
        • 8.3.7.2. Market Size and Forecast, By Technology
        • 8.3.7.3. Market Size and Forecast, By Application
        • 8.3.7.4. Market Size and Forecast, By End User
      • 8.3.8. Germany 3d Drug Eluting Balloons Applications In Healthcare Market

        • 8.3.8.1. Market Size and Forecast, By Component
        • 8.3.8.2. Market Size and Forecast, By Technology
        • 8.3.8.3. Market Size and Forecast, By Application
        • 8.3.8.4. Market Size and Forecast, By End User
      • 8.3.9. Italy 3d Drug Eluting Balloons Applications In Healthcare Market

        • 8.3.9.1. Market Size and Forecast, By Component
        • 8.3.9.2. Market Size and Forecast, By Technology
        • 8.3.9.3. Market Size and Forecast, By Application
        • 8.3.9.4. Market Size and Forecast, By End User
      • 8.3.10. Spain 3d Drug Eluting Balloons Applications In Healthcare Market

        • 8.3.10.1. Market Size and Forecast, By Component
        • 8.3.10.2. Market Size and Forecast, By Technology
        • 8.3.10.3. Market Size and Forecast, By Application
        • 8.3.10.4. Market Size and Forecast, By End User
      • 8.3.11. UK 3d Drug Eluting Balloons Applications In Healthcare Market

        • 8.3.11.1. Market Size and Forecast, By Component
        • 8.3.11.2. Market Size and Forecast, By Technology
        • 8.3.11.3. Market Size and Forecast, By Application
        • 8.3.11.4. Market Size and Forecast, By End User
      • 8.3.12. Russia 3d Drug Eluting Balloons Applications In Healthcare Market

        • 8.3.12.1. Market Size and Forecast, By Component
        • 8.3.12.2. Market Size and Forecast, By Technology
        • 8.3.12.3. Market Size and Forecast, By Application
        • 8.3.12.4. Market Size and Forecast, By End User
      • 8.3.13. Rest Of Europe 3d Drug Eluting Balloons Applications In Healthcare Market

        • 8.3.13.1. Market Size and Forecast, By Component
        • 8.3.13.2. Market Size and Forecast, By Technology
        • 8.3.13.3. Market Size and Forecast, By Application
        • 8.3.13.4. Market Size and Forecast, By End User
    • 8.4. Asia-Pacific

      • 8.4.1. Key Market Trends and Opportunities

      • 8.4.2. Market Size and Forecast, By Component

      • 8.4.3. Market Size and Forecast, By Technology

      • 8.4.4. Market Size and Forecast, By Application

      • 8.4.5. Market Size and Forecast, By End User

      • 8.4.6. Market Size and Forecast, By Country

      • 8.4.7. China 3d Drug Eluting Balloons Applications In Healthcare Market

        • 8.4.7.1. Market Size and Forecast, By Component
        • 8.4.7.2. Market Size and Forecast, By Technology
        • 8.4.7.3. Market Size and Forecast, By Application
        • 8.4.7.4. Market Size and Forecast, By End User
      • 8.4.8. Japan 3d Drug Eluting Balloons Applications In Healthcare Market

        • 8.4.8.1. Market Size and Forecast, By Component
        • 8.4.8.2. Market Size and Forecast, By Technology
        • 8.4.8.3. Market Size and Forecast, By Application
        • 8.4.8.4. Market Size and Forecast, By End User
      • 8.4.9. India 3d Drug Eluting Balloons Applications In Healthcare Market

        • 8.4.9.1. Market Size and Forecast, By Component
        • 8.4.9.2. Market Size and Forecast, By Technology
        • 8.4.9.3. Market Size and Forecast, By Application
        • 8.4.9.4. Market Size and Forecast, By End User
      • 8.4.10. South Korea 3d Drug Eluting Balloons Applications In Healthcare Market

        • 8.4.10.1. Market Size and Forecast, By Component
        • 8.4.10.2. Market Size and Forecast, By Technology
        • 8.4.10.3. Market Size and Forecast, By Application
        • 8.4.10.4. Market Size and Forecast, By End User
      • 8.4.11. Australia 3d Drug Eluting Balloons Applications In Healthcare Market

        • 8.4.11.1. Market Size and Forecast, By Component
        • 8.4.11.2. Market Size and Forecast, By Technology
        • 8.4.11.3. Market Size and Forecast, By Application
        • 8.4.11.4. Market Size and Forecast, By End User
      • 8.4.12. Thailand 3d Drug Eluting Balloons Applications In Healthcare Market

        • 8.4.12.1. Market Size and Forecast, By Component
        • 8.4.12.2. Market Size and Forecast, By Technology
        • 8.4.12.3. Market Size and Forecast, By Application
        • 8.4.12.4. Market Size and Forecast, By End User
      • 8.4.13. Malaysia 3d Drug Eluting Balloons Applications In Healthcare Market

        • 8.4.13.1. Market Size and Forecast, By Component
        • 8.4.13.2. Market Size and Forecast, By Technology
        • 8.4.13.3. Market Size and Forecast, By Application
        • 8.4.13.4. Market Size and Forecast, By End User
      • 8.4.14. Indonesia 3d Drug Eluting Balloons Applications In Healthcare Market

        • 8.4.14.1. Market Size and Forecast, By Component
        • 8.4.14.2. Market Size and Forecast, By Technology
        • 8.4.14.3. Market Size and Forecast, By Application
        • 8.4.14.4. Market Size and Forecast, By End User
      • 8.4.15. Rest of Asia Pacific 3d Drug Eluting Balloons Applications In Healthcare Market

        • 8.4.15.1. Market Size and Forecast, By Component
        • 8.4.15.2. Market Size and Forecast, By Technology
        • 8.4.15.3. Market Size and Forecast, By Application
        • 8.4.15.4. Market Size and Forecast, By End User
    • 8.5. LAMEA

      • 8.5.1. Key Market Trends and Opportunities

      • 8.5.2. Market Size and Forecast, By Component

      • 8.5.3. Market Size and Forecast, By Technology

      • 8.5.4. Market Size and Forecast, By Application

      • 8.5.5. Market Size and Forecast, By End User

      • 8.5.6. Market Size and Forecast, By Country

      • 8.5.7. Brazil 3d Drug Eluting Balloons Applications In Healthcare Market

        • 8.5.7.1. Market Size and Forecast, By Component
        • 8.5.7.2. Market Size and Forecast, By Technology
        • 8.5.7.3. Market Size and Forecast, By Application
        • 8.5.7.4. Market Size and Forecast, By End User
      • 8.5.8. South Africa 3d Drug Eluting Balloons Applications In Healthcare Market

        • 8.5.8.1. Market Size and Forecast, By Component
        • 8.5.8.2. Market Size and Forecast, By Technology
        • 8.5.8.3. Market Size and Forecast, By Application
        • 8.5.8.4. Market Size and Forecast, By End User
      • 8.5.9. Saudi Arabia 3d Drug Eluting Balloons Applications In Healthcare Market

        • 8.5.9.1. Market Size and Forecast, By Component
        • 8.5.9.2. Market Size and Forecast, By Technology
        • 8.5.9.3. Market Size and Forecast, By Application
        • 8.5.9.4. Market Size and Forecast, By End User
      • 8.5.10. UAE 3d Drug Eluting Balloons Applications In Healthcare Market

        • 8.5.10.1. Market Size and Forecast, By Component
        • 8.5.10.2. Market Size and Forecast, By Technology
        • 8.5.10.3. Market Size and Forecast, By Application
        • 8.5.10.4. Market Size and Forecast, By End User
      • 8.5.11. Argentina 3d Drug Eluting Balloons Applications In Healthcare Market

        • 8.5.11.1. Market Size and Forecast, By Component
        • 8.5.11.2. Market Size and Forecast, By Technology
        • 8.5.11.3. Market Size and Forecast, By Application
        • 8.5.11.4. Market Size and Forecast, By End User
      • 8.5.12. Rest of LAMEA 3d Drug Eluting Balloons Applications In Healthcare Market

        • 8.5.12.1. Market Size and Forecast, By Component
        • 8.5.12.2. Market Size and Forecast, By Technology
        • 8.5.12.3. Market Size and Forecast, By Application
        • 8.5.12.4. Market Size and Forecast, By End User
  • CHAPTER 9: COMPETITIVE LANDSCAPE

    • 9.1. Introduction

    • 9.2. Top Winning Strategies

    • 9.3. Product Mapping Of Top 10 Player

    • 9.4. Competitive Dashboard

    • 9.5. Competitive Heatmap

    • 9.6. Top Player Positioning, 2024

  • CHAPTER 10: COMPANY PROFILES

    • 10.1. Boston Scientific

      • 10.1.1. Company Overview

      • 10.1.2. Key Executives

      • 10.1.3. Company Snapshot

      • 10.1.4. Operating Business Segments

      • 10.1.5. Product Portfolio

      • 10.1.6. Business Performance

      • 10.1.7. Key Strategic Moves and Developments

    • 10.2. Medtronic

      • 10.2.1. Company Overview

      • 10.2.2. Key Executives

      • 10.2.3. Company Snapshot

      • 10.2.4. Operating Business Segments

      • 10.2.5. Product Portfolio

      • 10.2.6. Business Performance

      • 10.2.7. Key Strategic Moves and Developments

    • 10.3. Cook Medical

      • 10.3.1. Company Overview

      • 10.3.2. Key Executives

      • 10.3.3. Company Snapshot

      • 10.3.4. Operating Business Segments

      • 10.3.5. Product Portfolio

      • 10.3.6. Business Performance

      • 10.3.7. Key Strategic Moves and Developments

    • 10.4. Biosensors International

      • 10.4.1. Company Overview

      • 10.4.2. Key Executives

      • 10.4.3. Company Snapshot

      • 10.4.4. Operating Business Segments

      • 10.4.5. Product Portfolio

      • 10.4.6. Business Performance

      • 10.4.7. Key Strategic Moves and Developments

    • 10.5. TERUMO Corporation

      • 10.5.1. Company Overview

      • 10.5.2. Key Executives

      • 10.5.3. Company Snapshot

      • 10.5.4. Operating Business Segments

      • 10.5.5. Product Portfolio

      • 10.5.6. Business Performance

      • 10.5.7. Key Strategic Moves and Developments

    • 10.6. Biotronik SE And Co. KG

      • 10.6.1. Company Overview

      • 10.6.2. Key Executives

      • 10.6.3. Company Snapshot

      • 10.6.4. Operating Business Segments

      • 10.6.5. Product Portfolio

      • 10.6.6. Business Performance

      • 10.6.7. Key Strategic Moves and Developments

    • 10.7. Abbot Vascular

      • 10.7.1. Company Overview

      • 10.7.2. Key Executives

      • 10.7.3. Company Snapshot

      • 10.7.4. Operating Business Segments

      • 10.7.5. Product Portfolio

      • 10.7.6. Business Performance

      • 10.7.7. Key Strategic Moves and Developments

    • 10.8. C.R.Bard Inc.

      • 10.8.1. Company Overview

      • 10.8.2. Key Executives

      • 10.8.3. Company Snapshot

      • 10.8.4. Operating Business Segments

      • 10.8.5. Product Portfolio

      • 10.8.6. Business Performance

      • 10.8.7. Key Strategic Moves and Developments

    • 10.9. Cardionovum GmbH

      • 10.9.1. Company Overview

      • 10.9.2. Key Executives

      • 10.9.3. Company Snapshot

      • 10.9.4. Operating Business Segments

      • 10.9.5. Product Portfolio

      • 10.9.6. Business Performance

      • 10.9.7. Key Strategic Moves and Developments

    • 10.10. MicroPort Scientific Corporation

      • 10.10.1. Company Overview

      • 10.10.2. Key Executives

      • 10.10.3. Company Snapshot

      • 10.10.4. Operating Business Segments

      • 10.10.5. Product Portfolio

      • 10.10.6. Business Performance

      • 10.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET FOR DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET FOR MATERIALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET FOR SERVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET FOR DROPLET DEPOSITION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET FOR PHOTO POLYMERIZATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET FOR LASER BEAM MELTING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET FOR ELECTRONIC BEAM MELTING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET FOR LAMINATED OBJECT MANUFACTURING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET FOR EXTERNAL WEARABLE DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET FOR CLINICAL STUDY DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET FOR IMPLANTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET FOR TISSUE ENGINEERING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. GLOBAL 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 17. GLOBAL 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET FOR MEDICAL AND SURGICAL CENTERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 18. GLOBAL 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 19. GLOBAL 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET FOR ACADEMIC INSTITUTIONS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 20. GLOBAL 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 21. NORTH AMERICA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 22. NORTH AMERICA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 23. NORTH AMERICA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 24. NORTH AMERICA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 25. NORTH AMERICA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 26. U.S. 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 27. U.S. 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 28. U.S. 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 29. U.S. 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 30. CANADA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 31. CANADA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 32. CANADA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 33. CANADA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 34. MEXICO 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 35. MEXICO 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 36. MEXICO 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 37. MEXICO 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 38. EUROPE 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 39. EUROPE 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 40. EUROPE 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 41. EUROPE 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 42. EUROPE 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 43. FRANCE 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 44. FRANCE 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 45. FRANCE 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 46. FRANCE 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 47. GERMANY 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 48. GERMANY 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 49. GERMANY 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 50. GERMANY 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 51. ITALY 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 52. ITALY 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 53. ITALY 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 54. ITALY 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 55. SPAIN 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 56. SPAIN 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 57. SPAIN 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 58. SPAIN 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 59. UK 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 60. UK 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 61. UK 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 62. UK 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 63. RUSSIA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 64. RUSSIA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 65. RUSSIA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 66. RUSSIA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 67. REST OF EUROPE 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 68. REST OF EUROPE 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 69. REST OF EUROPE 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 70. REST OF EUROPE 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 71. ASIA-PACIFIC 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 72. ASIA-PACIFIC 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 73. ASIA-PACIFIC 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 74. ASIA-PACIFIC 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 75. ASIA-PACIFIC 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 76. CHINA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 77. CHINA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 78. CHINA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 79. CHINA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 80. JAPAN 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 81. JAPAN 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 82. JAPAN 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 83. JAPAN 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 84. INDIA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 85. INDIA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 86. INDIA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 87. INDIA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 88. SOUTH KOREA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 89. SOUTH KOREA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 90. SOUTH KOREA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 91. SOUTH KOREA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 92. AUSTRALIA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 93. AUSTRALIA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 94. AUSTRALIA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 95. AUSTRALIA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 96. THAILAND 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 97. THAILAND 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 98. THAILAND 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 99. THAILAND 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 100. MALAYSIA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 101. MALAYSIA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 102. MALAYSIA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 103. MALAYSIA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 104. INDONESIA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 105. INDONESIA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 106. INDONESIA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 107. INDONESIA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 108. REST OF ASIA PACIFIC 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 109. REST OF ASIA PACIFIC 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 110. REST OF ASIA PACIFIC 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 111. REST OF ASIA PACIFIC 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 112. LAMEA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 113. LAMEA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 114. LAMEA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 115. LAMEA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 116. LAMEA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 117. BRAZIL 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 118. BRAZIL 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 119. BRAZIL 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 120. BRAZIL 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 121. SOUTH AFRICA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 122. SOUTH AFRICA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 123. SOUTH AFRICA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 124. SOUTH AFRICA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 125. SAUDI ARABIA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 126. SAUDI ARABIA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 127. SAUDI ARABIA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 128. SAUDI ARABIA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 129. UAE 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 130. UAE 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 131. UAE 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 132. UAE 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 133. ARGENTINA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 134. ARGENTINA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 135. ARGENTINA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 136. ARGENTINA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 137. REST OF LAMEA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 138. REST OF LAMEA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 139. REST OF LAMEA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 140. REST OF LAMEA 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 141. BOSTON SCIENTIFIC: KEY EXECUTIVES
  • TABLE 142. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
  • TABLE 143. BOSTON SCIENTIFIC: OPERATING SEGMENTS
  • TABLE 144. BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
  • TABLE 145. BOSTON SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 146. MEDTRONIC: KEY EXECUTIVES
  • TABLE 147. MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 148. MEDTRONIC: OPERATING SEGMENTS
  • TABLE 149. MEDTRONIC: PRODUCT PORTFOLIO
  • TABLE 150. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 151. COOK MEDICAL: KEY EXECUTIVES
  • TABLE 152. COOK MEDICAL: COMPANY SNAPSHOT
  • TABLE 153. COOK MEDICAL: OPERATING SEGMENTS
  • TABLE 154. COOK MEDICAL: PRODUCT PORTFOLIO
  • TABLE 155. COOK MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 156. BIOSENSORS INTERNATIONAL: KEY EXECUTIVES
  • TABLE 157. BIOSENSORS INTERNATIONAL: COMPANY SNAPSHOT
  • TABLE 158. BIOSENSORS INTERNATIONAL: OPERATING SEGMENTS
  • TABLE 159. BIOSENSORS INTERNATIONAL: PRODUCT PORTFOLIO
  • TABLE 160. BIOSENSORS INTERNATIONAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 161. TERUMO CORPORATION: KEY EXECUTIVES
  • TABLE 162. TERUMO CORPORATION: COMPANY SNAPSHOT
  • TABLE 163. TERUMO CORPORATION: OPERATING SEGMENTS
  • TABLE 164. TERUMO CORPORATION: PRODUCT PORTFOLIO
  • TABLE 165. TERUMO CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 166. BIOTRONIK SE AND CO. KG: KEY EXECUTIVES
  • TABLE 167. BIOTRONIK SE AND CO. KG: COMPANY SNAPSHOT
  • TABLE 168. BIOTRONIK SE AND CO. KG: OPERATING SEGMENTS
  • TABLE 169. BIOTRONIK SE AND CO. KG: PRODUCT PORTFOLIO
  • TABLE 170. BIOTRONIK SE AND CO. KG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 171. ABBOT VASCULAR: KEY EXECUTIVES
  • TABLE 172. ABBOT VASCULAR: COMPANY SNAPSHOT
  • TABLE 173. ABBOT VASCULAR: OPERATING SEGMENTS
  • TABLE 174. ABBOT VASCULAR: PRODUCT PORTFOLIO
  • TABLE 175. ABBOT VASCULAR: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 176. C.R.BARD INC.: KEY EXECUTIVES
  • TABLE 177. C.R.BARD INC.: COMPANY SNAPSHOT
  • TABLE 178. C.R.BARD INC.: OPERATING SEGMENTS
  • TABLE 179. C.R.BARD INC.: PRODUCT PORTFOLIO
  • TABLE 180. C.R.BARD INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 181. CARDIONOVUM GMBH: KEY EXECUTIVES
  • TABLE 182. CARDIONOVUM GMBH: COMPANY SNAPSHOT
  • TABLE 183. CARDIONOVUM GMBH: OPERATING SEGMENTS
  • TABLE 184. CARDIONOVUM GMBH: PRODUCT PORTFOLIO
  • TABLE 185. CARDIONOVUM GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 186. MICROPORT SCIENTIFIC CORPORATION: KEY EXECUTIVES
  • TABLE 187. MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 188. MICROPORT SCIENTIFIC CORPORATION: OPERATING SEGMENTS
  • TABLE 189. MICROPORT SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 190. MICROPORT SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET SEGMENTATION
  • FIGURE 2. GLOBAL 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET
  • FIGURE 3. SEGMENTATION 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBAL3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET
  • FIGURE 11. 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET SEGMENTATION, BY BY COMPONENT
  • FIGURE 12. 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET FOR DEVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET FOR MATERIALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET FOR SERVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET SEGMENTATION, BY BY TECHNOLOGY
  • FIGURE 16. 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET FOR DROPLET DEPOSITION, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET FOR PHOTO POLYMERIZATION, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET FOR LASER BEAM MELTING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET FOR ELECTRONIC BEAM MELTING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET FOR LAMINATED OBJECT MANUFACTURING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 22. 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET FOR EXTERNAL WEARABLE DEVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET FOR CLINICAL STUDY DEVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET FOR IMPLANTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET FOR TISSUE ENGINEERING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 26. 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET SEGMENTATION, BY BY END USER
  • FIGURE 27. 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET FOR MEDICAL AND SURGICAL CENTERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 28. 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 29. 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET FOR ACADEMIC INSTITUTIONS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 30. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 31. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 32. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 33. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 34. COMPETITIVE DASHBOARD
  • FIGURE 35. COMPETITIVE HEATMAP: 3D DRUG ELUTING BALLOONS APPLICATIONS IN HEALTHCARE MARKET
  • FIGURE 36. TOP PLAYER POSITIONING, 2024
  • FIGURE 37. BOSTON SCIENTIFIC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 38. BOSTON SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 39. BOSTON SCIENTIFIC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 40. MEDTRONIC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 41. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 42. MEDTRONIC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 43. COOK MEDICAL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 44. COOK MEDICAL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 45. COOK MEDICAL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 46. BIOSENSORS INTERNATIONAL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 47. BIOSENSORS INTERNATIONAL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 48. BIOSENSORS INTERNATIONAL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 49. TERUMO CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 50. TERUMO CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 51. TERUMO CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 52. BIOTRONIK SE AND CO. KG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 53. BIOTRONIK SE AND CO. KG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 54. BIOTRONIK SE AND CO. KG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 55. ABBOT VASCULAR: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 56. ABBOT VASCULAR: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 57. ABBOT VASCULAR: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 58. C.R.BARD INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 59. C.R.BARD INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 60. C.R.BARD INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 61. CARDIONOVUM GMBH: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 62. CARDIONOVUM GMBH: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 63. CARDIONOVUM GMBH: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 64. MICROPORT SCIENTIFIC CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 65. MICROPORT SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 66. MICROPORT SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
3D Drug Eluting Balloons Applications in Healthcare Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue